Biomedical Engineering Reference
In-Depth Information
[21]
Weih, F., Carrasco, D., and Bravo, R., Constitutive and inducible Rel/NF-kappaB
activities in mouse thymus and spleen,
Oncogene,
9, 3289, 1994.
[22]
Alcamo, E., Hacohen, N., Schulte, L.C.
et al., Requirement for the NF-kappaB family
member RelA in the development of secondary lymphoid organs,
J. Exp. Med.,
195,
233, 2002.
[23]
Miyawaki, S., Nakamura, Y., Suzuka, H.
et al., A new mutation, aly, that induces a
generalized lack of lymph nodes accompanied by immunodeficiency in mice,
Eur. J.
Immunol.,
24, 429, 1994.
[24]
Koike, R., Nishimura, T., Yasumizu, R.
et al., The splenic marginal zone is absent in
alymphoplastic aly mutant mice,
Eur. J. Immunol.,
26, 669, 1996.
[25]
Shinkura, R., Kitada, K., Matsuda, F.
et al., Alymphoplasia is caused by a point
mutation in the mouse gene encoding NF-kappaB-inducing kinase,
Nat. Genet.,
22,
74, 1999.
[26]
Yilmaz, Z.B., Weih, D.S., Sivakumar, V.
et al., RelB is required for Peyer's patch
development: Differential regulation of p52-RelB by lymphotoxin and TNF,
Embo
J.,
22, 121, 2003.
[27]
Paxian, S., Merkle, H., Riemann, M.
et al., Abnormal organogenesis of Peyer's
patches in mice deficient for NF-kappaB1, NF-kappaB2, and Bcl-3,
Gastroenterol.,
122, 1853, 2002.
[28]
Caamano, J.H., Rizzo, C.A., Durham, S.K.
et al., Nuclear factor (NF)-kappaB2
(p100/p52) is required for normal splenic microarchitecture and B cell-mediated
immune responses,
J. Exp. Med.,
187, 185, 1998.
[29]
Franzoso, G., Carlson, L., Poljak, L.
et al., Mice deficient in nuclear factor
(NF)-kappaB/p52 present with defects in humoral responses, germinal center reac-
tions, and splenic microarchitecture,
J. Exp. Med.,
187, 147, 1998.
[30]
Bonizzi, G. and Karin, M., The two NF-kappaB activation pathways and their role
in innate and adaptive immunity,
Trends Immunol.,
25, 280, 2004.
[31]
Weih, D.S., Yilmaz, Z.B., and Weih, F., Essential role of RelB in germinal center and
marginal zone formation and proper expression of homing chemokines,
J. Immunol.,
167, 1909, 2001.
[32]
Schwarz, E.M., Krimpenfort, P., Berns, A.
et al., Immunological defects in mice with
a targeted disruption in Bcl-3,
Genes Dev.,
11, 187, 1997.
[33]
Caamano, J.H., Perez, P., Lira, S.A.
et al., Constitutive expression of Bc1-3 in
thymocytes increases the DNA binding of NF-kappaB1 (p50) homodimers in vivo,
Mol. Cell. Biol.,
16, 1342, 1996.
[34]
Sha, W.C., Liou, H.C., Tuomanen, E.I.
et al., Targeted disruption of the p50 subunit
of NF-kappaB leads to multifocal defects in immune responses,
Cell,
80, 321, 1995.
[35]
Sentman, C.L., Shutter, J.R., Hockenbery, D.
et al., bcl-2 inhibits multiple forms of
apoptosis but not negative selection in thymocytes,
Cell,
67, 879, 1991.
[36]
Horwitz, B.H., Scott, M.L., Cherry, S.R.
et al., Failure of lymphopoiesis after adoptive
transfer of NF-kappaB-deficient fetal liver cells,
Immunity,
6, 765, 1997.
[37]
Grossmann, M., Metcalf, D., Merryfull, J.
et al., The combined absence of the
transcription factors Rel and RelA leads to multiple hemopoietic cell defects,
Proc.
Natl. Acad. Sci. USA,
96, 11848, 1999.
[38]
Pyatt, D.W., Stillman, W.S., Yang, Y.
et al., An essential role for NF-kappaB in human
CD34(+) bone marrow cell survival,
Blood,
93, 3302, 1999.
[39]
Voll, R.E., Jimi, E., Phillips, R.J.
et al., NF-kappaB activation by the pre-T cell
receptor serves as a selective survival signal in T lymphocyte development,
Immunity,
13, 677, 2000.
